The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity

The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity

In this review work, the authors emphasize the discussion on different emerging variants of SARS-CoV-2 and vaccine effectiveness against them [...]

Bibliographic Details
Main Authors:	Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, Pankti Balar
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	Vaccines
Subjects:	n/a
Online Access:	https://www.mdpi.com/2076-393X/11/4/764

Similar Items

Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2
by: Vivek P. Chavda, et al.
Published: (2022-12-01)

Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
by: Divya Teli, et al.
Published: (2023-02-01)

Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
by: Vivek P. Chavda, et al.
Published: (2023-01-01)

Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants
by: Vivek P. Chavda, et al.
Published: (2023-02-01)

Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes
by: Vivek P. Chavda, et al.
Published: (2022-07-01)

Use of Hand Sanitizers in COVID-19 Prevention: A Comprehensive Overview
by: Suneetha Vuppu, et al.
Published: (2023-08-01)

SARS-CoV-2: Immunopeptidomics and Other Immunological Studies
by: Vivek P. Chavda, et al.
Published: (2022-11-01)

Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population
by: Vivek P. Chavda, et al.
Published: (2023-03-01)

A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
by: Vivek P Chavda, et al.
Published: (2021-06-01)

Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
by: Vivek P. Chavda, et al.
Published: (2022-02-01)

Post-COVID-19 Fungal Infection in the Aged Population
by: Vivek P. Chavda, et al.
Published: (2023-02-01)

Supporting the Aspecific Physiological Defenses of Upper Airways against Emerging SARS-CoV-2 Variants
by: Luca Cegolon, et al.
Published: (2023-01-01)

Combatting infectious diarrhea: innovations in treatment and vaccination strategies
by: Vivek P. Chavda, et al.
Published: (2024-12-01)

Global Analysis of Tracking the Evolution of SARS-CoV-2 Variants
by: Muhammad Atif Zahoor
Published: (2023-12-01)

Approaching Challenges Posed by SARS-CoV-2 Genetic Variants
by: José de la Fuente
Published: (2022-11-01)

Emerging SARS-CoV-2 variants expand species tropism to murines
by: Huiping Shuai, et al.
Published: (2021-11-01)

Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein
by: Gerco den Hartog, et al.
Published: (2023-10-01)

The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
by: Vivek P. Chavda, et al.
Published: (2022-11-01)

Emerging Trends in Complications Associated with SARS-CoV-2 Infection
by: Elena Cecilia Rosca, et al.
Published: (2023-12-01)

An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants
by: Timothy A. Bates, et al.
Published: (2023-03-01)

The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants
by: Thompson, RN, et al.
Published: (2023)

The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants
by: Robin N. Thompson, et al.
Published: (2023-01-01)

Complementarity determining regions in SARS-CoV-2 hybrid immunity
by: Glynis Frans, et al.
Published: (2023-02-01)

Measles Virus-Induced Immune Amnesia and SARS-CoV-2 Evolution
by: Giovanni Di Guardo
Published: (2024-03-01)

Special Issue “SARS-CoV-2 Innate and Adaptive Immune Responses”
by: Rémi Planes, et al.
Published: (2022-10-01)

Special Issue “Advances in Antiviral Agents against SARS-CoV-2 and Its Variants”
by: Francesca Esposito, et al.
Published: (2023-09-01)

Genes of SARS-CoV-2 and emerging variants
by: Ian Macreadie, et al.
Published: (2021-01-01)

COVID-19 Era and the Constantly Reemerging Novel SARS-CoV-2 Variants Calls for Special Attention for the Geriatrics: A Real Challenge
by: L. V. Simhachalam Kutikuppala, et al.
Published: (2022-12-01)

Propolis and Their Active Constituents for Chronic Diseases
by: Vivek P. Chavda, et al.
Published: (2023-01-01)

Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections
by: Luis Martinez-Sobrido, et al.
Published: (2023-02-01)

What SARS-CoV-2 Variants Have Taught Us: Evolutionary Challenges of RNA Viruses
by: Shymaa E. Bilasy, et al.
Published: (2024-01-01)

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
by: Skelly, DT, et al.
Published: (2021)

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
by: Donal T. Skelly, et al.
Published: (2021-08-01)

In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential
by: Brandon Lam, et al.
Published: (2021-10-01)

Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants
by: Shuqi Wang, et al.
Published: (2024-02-01)

SARS-CoV-2 variants of concern: a review
by: Malay S. Sarkar, et al.
Published: (2022-10-01)

Outcomes associated with SARS-CoV-2 reinfection in individuals with natural and hybrid immunity
by: Geehan Suleyman, et al.
Published: (2023-08-01)

The Emerging Concern and Interest SARS-CoV-2 Variants
by: Edyta Janik, et al.
Published: (2021-05-01)

The emergence, dynamics and significance of SARS-CoV-2 variants
by: Philippe COLSON, et al.
Published: (2022-01-01)

Evolutionary trajectory of SARS-CoV-2 and emerging variants
by: Jalen Singh, et al.
Published: (2021-08-01)